Krill openedthe door.We went beyond.

The Category Doesn’t Need
Another Source.It needs a better
lipid architecture

Krill helped the market understand that the way omega-3 is
carried matters. Beyond Krill takes that insight further.

Instead of accepting what nature happens to provide, we use
enzymatic biotechnology to design a phospholipid omega-3
with more of what matters, bonded EPA and DHA.

Don’t just count phospholipids.
Ask how much Omega-3 is bonded to them

**Comparative statements refer to the conceptual BeyondKrill™ formulation and typical krill oil benchmarks. Final claims depend on formulation, dosage, market and regulatory review.

Explore The Possibilities

BeyondKrill Starts Here.

High-Strength
EPA+DHA Formula
Powered by Ruby-O®
BPL-O3™ Technology

BeyondKrill is more than a single ingredient. It's a new territory for phospholipid omega-3 innovation, powered by Ruby-O® technology.

Our high-strength formulation is one example of what's possible: delivering 450 mg of EPA+DHA, more phospholipids bonded to EPA+DHA, and a 100% shellfish-free alternative to conventional krill oil.

• Heart health
• Brain health
• Healthy aging
• Prenatal nutrition
• Active & daily wellness

• 2X: The EPA+DHA concentration of conventional krill oil.
• More Bonded: Phospholipids bonded to EPA+DHA.
• Shellfish Free: Made without shellfish-derived ingredients.
• Science Driven: Powered by Ruby-O® BPL-O3™ technology.

Conceptual product representation. Formulation powered by Ruby-O®.

POWERED BY

Bonded.
Not blended.

Ruby-O® is Naturmega’s patented BPL-O3™
platform. Through enzymatic biotechnology,
omega-3 fatty acids are structurally bonded to
phospholipids, creating a biomimetic lipid
system designed for efficient incorporation and
flexible product development.

EPA and DHA become part
of the phospholipid
structure itself, not simply
mixed alongside it.

CLINICAL SIGNAL

“In a 12-week clinical study, Ruby-O®
delivered a 34% greater increase in Omega-3
Index per mg than standard fish oil.”

Study population n=44. Ruby-O® 825 mg/day vs. fish oil 903 mg/day. Evidence relates to the Ruby-O® technology platform; it is not a disease claim.

What could
your brand
create with
BeyondKrill™?

One breakthrough ingredient.
Multiple consumer territories. Your
brand leads the story.

Beyond A Product.
A Territory To Own.

READY TO GO BEYOND?

Your next omega-3
idea starts here.

Tell us what your brand wants to create.
Naturmega’s lipid experts can help take it from
possibility to formulation and scale.